Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

The ESPAC-1, ESPAC-1 plus, and early ESPAC-3(v1) results (458 randomized patients; 364 deaths) were used to estimate the effectiveness of adjuvant 5FU/FA vs resection alone for pancreatic cancer using meta-analysis. The pooled hazard ratio of 0.70 (95% CI=0.55–0.88) P=0.003, and the median survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Neoptolemos, J P, Stocken, D D, Tudur Smith, C, Bassi, C, Ghaneh, P, Owen, E, Moore, M, Padbury, R, Doi, R, Smith, D, Büchler, M W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2625958/
https://www.ncbi.nlm.nih.gov/pubmed/19127260
http://dx.doi.org/10.1038/sj.bjc.6604838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2625958/
https://www.ncbi.nlm.nih.gov/pubmed/19127260
http://dx.doi.org/10.1038/sj.bjc.6604838

Ejemplares similares